Ocugen, Inc. Gains 66.62%

Ocugen, Inc. (OCGN:NASDAQ) jumped higher at $0.63, a gain of 66.6%. On Fri 24 Jul 20, OCGN:NASDAQ touched a New 2-Week Intraday High of $0.41. The stock got featured on our News Catalysts scanner on Mon 27 Jul 20 at 08:11 AM in the 'BIOTECH' category. From Fri 10 Jul 20, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Tue 21 Jul 20 at $0.5 with a volume of 215M+.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).